874 related articles for article (PubMed ID: 18780260)
21. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.
Kempen JH; Martin BK; Wu AW; Barron B; Thorne JE; Jabs DA;
Ophthalmology; 2003 May; 110(5):987-95. PubMed ID: 12750102
[TBL] [Abstract][Full Text] [Related]
22. [Indications for eye examination of HIV patients--screening parameters for cytomegalovirus retinitis].
Gellrich MM; Lagrèze WD; Rump JA; Hansen LL
Klin Monbl Augenheilkd; 1996; 209(2-3):72-8. PubMed ID: 8992086
[TBL] [Abstract][Full Text] [Related]
23. Ophthalmic manifestations in people living with HIV attending a tertiary care centre of Eastern India.
Biswas PN; Saha B; Ghosh S; Mallik S; Nandi K; Niyogi DK; Bhaduri G
J Indian Med Assoc; 2008 May; 106(5):292-4. PubMed ID: 18839634
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of the ocular complications of HIV infection in Chiang Mai.
Ausayakhun S; Watananikorn S; Ittipunkul N; Chaidaroon W; Patikulsila P; Patikulsila D
J Med Assoc Thai; 2003 May; 86(5):399-406. PubMed ID: 12859094
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of ocular manifestations and blindness in HIV/AIDS patients in a tertiary care hospital in South India.
Ganekal S; Jhanji V; Dorairaj S; Nagarajappa A
Ocul Immunol Inflamm; 2012 Oct; 20(5):336-41. PubMed ID: 22775065
[TBL] [Abstract][Full Text] [Related]
26. Ophthalmic manifestations of HIV in the highly active anti-retroviral therapy era.
Mowatt L
West Indian Med J; 2013; 62(4):305-12. PubMed ID: 24756590
[TBL] [Abstract][Full Text] [Related]
27. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
[TBL] [Abstract][Full Text] [Related]
28. Kaposi's sarcoma in patients with human immunodeficiency virus infection in Taiwan.
Lin CY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Lo YC; Hung CC; Chang SC
J Microbiol Immunol Infect; 2009 Jun; 42(3):227-33. PubMed ID: 19812856
[TBL] [Abstract][Full Text] [Related]
29. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Kedhar SR; Jabs DA
Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
[TBL] [Abstract][Full Text] [Related]
30. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
31. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N
HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077
[TBL] [Abstract][Full Text] [Related]
32. Ocular tuberculosis in acquired immunodeficiency syndrome.
Babu RB; Sudharshan S; Kumarasamy N; Therese L; Biswas J
Am J Ophthalmol; 2006 Sep; 142(3):413-8. PubMed ID: 16935585
[TBL] [Abstract][Full Text] [Related]
33. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.
Sheng WH; Hung CC; Wu RJ; Wang JT; Chen PJ; Chang SC; Kao JH
Clin Infect Dis; 2007 Feb; 44(4):584-90. PubMed ID: 17243064
[TBL] [Abstract][Full Text] [Related]
34. Extensive retinal neovascularization as a late finding in human immunodeficiency virus-infected patients with immune recovery uveitis.
Wright ME; Suzman DL; Csaky KG; Masur H; Polis MA; Robinson MR
Clin Infect Dis; 2003 Apr; 36(8):1063-6. PubMed ID: 12684920
[TBL] [Abstract][Full Text] [Related]
35. AIDS and ophthalmology: the first quarter century.
Holland GN
Am J Ophthalmol; 2008 Mar; 145(3):397-408. PubMed ID: 18282490
[TBL] [Abstract][Full Text] [Related]
36. Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.
Mussini C; Manzardo C; Johnson M; Monforte Ad; Uberti-Foppa C; Antinori A; Gill MJ; Sighinolfi L; Borghi V; Lazzarin A; Miró JM; Sabin C;
AIDS; 2008 Nov; 22(18):2461-9. PubMed ID: 19005269
[TBL] [Abstract][Full Text] [Related]
37. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
[TBL] [Abstract][Full Text] [Related]
38. Outcomes associated with ganciclovir implants in patients with AIDS-related cytomegalovirus retinitis.
Kappel PJ; Charonis AC; Holland GN; Narayanan R; Kulkarni AD; Yu F; Boyer DS; Engstrom RE; Kuppermann BD;
Ophthalmology; 2006 Apr; 113(4):683.e1-8. PubMed ID: 16581428
[TBL] [Abstract][Full Text] [Related]
39. Causes of visual acuity loss among HIV-infected patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy in Chiang Mai University Hospital.
Tangmonkongvoragul C; Ausayakhun S
J Med Assoc Thai; 2012 Apr; 95 Suppl 4():S129-35. PubMed ID: 22696865
[TBL] [Abstract][Full Text] [Related]
40. HIV/AIDS in ophthalmic patients: The Guinness Eye Centre Onitsha experience.
Nwosu NN
Niger Postgrad Med J; 2008 Mar; 15(1):24-7. PubMed ID: 18408779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
